Affiliates' Research in Medical Journals, Spring 2020
Many NBER-affiliated researchers publish some of their findings in medical and other journals that preclude pre-publication distribution. This makes it impossible to include these papers in the NBER working paper series. This is a partial listing of recent papers in this category by NBER affiliates.
Opioid Deaths and Local Healthcare Intensity: A Longitudinal Analysis of the US Population, 2003–2014
Lin D, Liu S, Ruhm CJ. American Journal of Preventive Medicine 58(1), January 2020, pp. 50–58.
This study examines the association between county-level health care intensity and opioid death rates. Health care intensity is measured with an index, based on data from the Dartmouth Atlas of Health Care capturing regional variation in Medicare spending in the last two years of life. The study shows a positive correlation between health care intensity and opioid death rates. The relationship is non-linear, with the strongest relationship for counties in the highest quintile of health care intensity. The positive relationship could reflect several different mechanisms, such as differing patterns of opioid prescriptions or different rates of other interventions that affect opioid use. Controlling for the quantity of prescribed opioids attenuated, but did not fully eliminate, the positive association between HCI and opioid death rates. Non-opioid drug death rates were unrelated to health care intensity.
The Impact of Pharmaceutical Innovation on the Burden of Disease in Ireland, 2000–2015
Lichtenberg FR. Journal of Public Health, January 2020, fdz183.
This study performs an econometric assessment of the impact that pharmaceutical innovation had on the burden of disease in Ireland. Health is measured in terms of disability-adjusted life-years (DALYs) for 66 diseases, which captures the disease-related loss of "healthy life years" in the population due to disability from the health conditions as well as from premature mortality. The author uses a difference-in-differences (or two-way fixed effects) research design, investigating whether diseases for which more new drugs were launched had larger subsequent reductions in mortality. This design controls for the effects of general economic and societal factors (e.g. income, education, and behavioral risk factors), to the extent that those effects are similar across diseases. Appropriate lags (up to 18 years) are modeled for the effects of medications on subsequent health. New medications (chemical entities) launched during 1983–1997 are estimated to have reduced the total number of DALYs lost in 2015 by about 234,600. Pharmaceutical expenditure per DALY gained in 2015 from drugs launched during 1983–1997 was â‚¬1137, which indicates that the new drugs launched during 1983–1997 were very cost-effective, overall. (Interventions that avert one DALY for less than average per capita income for a given country or region are considered very costâ€“effectiveâ€™, and Irelandâ€™s per capita GDP was â‚¬55,756 in 2015).
Modeling Peer Effect Modification by Network Strength: The Diffusion of Implantable Cardioverter Defibrillators in the US Hospital Network
O'Malley AJ, Moen EL, Bynum JPW, Austin AM, Skinner JS. Statistics in Medicine 39(8), April 2020, pp. 1125–1144.
This paper develops a model of peer effects and applies it to the diffusion of implantable cardioverter defibrillators (ICDs) across hospitals for patients with congestive heart failure. It examines the influence of peer hospitals — those that share cardiovascular-disease patients — on a hospital's adoption and continuation of capability to implant ICDs. The researchers present evidence that exposure to ICD-capable peer hospitals is strongly associated with the likelihood that a hospital becomes ICD-capable, even after controlling for the effects of geography. The direction and magnitude of the peer effects depend on the degree of connection with peer hospitals. The results suggest that inter-hospital peer networks could help explain patterns of regional variations in health care utilization.
Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013
Yao J, Ghosh K, Perraillon MC, Cutler DM, Fang MC. Medical Care 57(4) April 2019, pp. 262–269.
Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose
Abouk R, Pacula RL, Powell D. JAMA Internal Medicine 179(6), May 2019, pp. 805–811.
Incorporating Prescription Drug Utilization Information into the Marketplace Risk Adjustment Model Improves Payment Accuracy and Reduces Adverse Selection Incentives
Xu J, Trish E, Joyce G. Medical Care Research and Review, August 2019.
The Impact of Pharmaceutical Innovation on the Burden of Disease in Canada, 2000-2016
Lichtenberg FR. SSM Population Health 8, August 2019, 100457.
Association Between Physician Adoption of a New Oral Anti-Diabetic Medication and Medicare and Medicaid Drug Spending
Metes ID, Xue L, Chang CH, Huskamp HA, Gellad WF, Lo-Ciganic WH, Choudhry NK, Richards-Shubik S, Guclu H, Donohue JM. BMC Health Services Research 19(1), October 2019, article 703.
Housing and Urban Development-Veterans Affairs Supportive Housing Vouchers and Veterans' Homelessness, 2007-2017
Evans WN, Kroeger S, Palmer C, Pohl E. American Journal of Public Health 109(10), October 2019, pp. 1440–1445.
Measuring Racial Segregation i Health System Networks Using the Dissimilarity Index
Austin AM, Carmichael DQ, Bynum JPW, Skinner JS. Social Science & Medicine 240, November 2019, 112570.
Longitudinal Analysis of Dementia Diagnosis and Specialty Care Among Racially Diverse Medicare Beneficiaries
Drabo EF, Barthold D, Joyce G, Ferido P, Chui HC, Zissimopoulos J. Alzheimer's & Dementia 15(11), November 2019, pp. 1402–1411.
Association of Receiving Multiple, Concurrent Fracture-Associated Drugs with Hip Fracture Risk
Emeny RT, Chang C, Skinner JS, O'Malley AJ, Smith J, Chakraborti G, Rosen CJ, Morden NE. JAMA Network Open 2(11), November 2019, e1915348.
Access to Care among Individuals Who Experienced Medicaid Lockouts After Premium Nonpayment
Saloner B, Dague L, Friedsam D, Voskuil K, Serna Borrero N, Burns M. JAMA Network Open 2(11), November 2019, e1914561.
Delivery System Performance as Financial Risk Varies
Newhouse JP, Price M, Hsu J, Landon B, McWilliams JM. American Journal of Managed Care 25(12), December 2019, pp. 294–300, also e388–94.
Physical Activity And Weight Following Car Ownership in Beijing, China: Quasi-Experimental Cross-Sectional Study
Anderson ML, Lu F, Yang J. BMJ, 367, December 2019, l6491.
The Impact of High Ambient Temperatures on Delivery Timing and Gestational Lengths
Barreca A, Schaller J. Nature Climate Change 10, December 2019, pp. 77-82.
Health Care Hotspotting - A Randomized, Controlled Trial
Finkelstein A, Zhou A, Taubman S, Doyle J. New England Journal of Medicine 382(2), January 2020, pp. 152–162.
How Cost-Effective are New Cancer Drugs in the US?
Lichtenberg FR. Expert Review of Pharmacoeconomics & Outcomes Research, January 2020, pp. 1–17.
Malpractice Liability and Health Care Quality: A Review
Mello MM, Frakes MD, Blumenkranz E, Studdert DM. JAMA 323(4), January 2020, pp. 352–366.
Architecting Process of Care: A Randomized Controlled Study Evaluating the Impact of Providing Nonadherence Information and Pharmacist Assistance to Physicians
McConnell M, Rogers W, Simeonova E, Wilson IB. Health Services Research 55(1), February 2020, pp. 136–145.
Renovating Subsidized Housing: The Impact on Health
Ellen IG, Dragan KL, Glied S. Health Affairs 39(2), February 2020, pp. 224-232.
The Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality: An Observational Study with a Regression Discontinuity Design
Anderson ML, Dobkin C, Gorry D. Annals of Internal Medicine, March 2020.